Indaptus Therapeutics (INDP)
Develops systemically administered bacterial immunotherapy for cancer and antiviral applications.
$1.16
Pre-market+0.01 (+1.08%)
At close$1.15(+1.33%)
Something off on this page? Send us feedback.
Next report
Nov 17, 2026
estimated · in 75 days
EPS estimate
−$1.46
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.38−$8.96−$9.09−$2.98−$3.10−$0.23−$0.02Pending
Estimate−$0.41−$11.48−$9.24−$4.17−$4.36−$1.87−$1.57−$1.46
Surprise+7.3%+22.0%+1.6%+28.5%+28.9%+87.7%+98.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.46 | — | — |
| Aug 2026 | −$1.57 | −$0.02 | +98.7% |
| May 2026 | −$1.87 | −$0.23 | +87.7% |
| Mar 2026 | −$4.36 | −$3.10 | +28.9% |
| Nov 2025 | −$4.17 | −$2.98 | +28.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Mar 2017 | |||
| Sep 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Apr 2015 | |||
| Jan 2015 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | −$1.46 | — | — | — | — | — | — |
| Aug 13, 2026 | −$1.57 | −$0.02 | +98.7% | — | — | — | +3.9% |
| May 15, 2026 | −$1.87 | −$0.23 | +87.7% | — | — | — | −4.4% |
| Mar 17, 2026 | −$4.36 | −$3.10 | +28.9% | — | — | — | −4.6% |
| Nov 12, 2025 | −$4.17 | −$2.98 | +28.5% | — | — | — | +2.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 17, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 13, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 15, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 9, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Aug 10, 2017 | |||||||
| Apr 7, 2017 | |||||||
| Mar 29, 2017 | |||||||
| Sep 1, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Jul 30, 2015 | |||||||
| Apr 27, 2015 | |||||||
| Jan 29, 2015 | — | — | — | — | — | — | — |